Illumina, Inc. (ILMN)
Largest Insider Buys in Sector
ILMN Stock Price History Chart
ILMN Stock Performance
About Illumina, Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as …
Insider Activity of Illumina, Inc.
Over the last 12 months, insiders at Illumina, Inc. have bought $991,672 and sold $0 worth of Illumina, Inc. stock.
On average, over the past 5 years, insiders at Illumina, Inc. have bought $991,672 and sold $22.43M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Thaysen Jacob (Chief Executive Officer) — $1.98M.
The last purchase of 7,330 shares for transaction amount of $991,672 was made by Thaysen Jacob (Chief Executive Officer) on 2024‑02‑22.
List of Insider Buy and Sell Transactions, Illumina, Inc.
| 2024-02-22 | Chief Executive Officer | 7,330 0.0046% | $135.29 | $991,672 | -3.99% | |||
| 2023-11-07 | Sale | SVP, Chief People Officer | 315 0.0002% | $112.84 | $35,545 | +13.48% | ||
| 2023-08-22 | Sale | SVP, Chief Commercial Officer | 500 0.0003% | $167.04 | $83,520 | -20.83% | ||
| 2023-07-24 | Sale | SVP, Chief Commercial Officer | 500 0.0003% | $190.08 | $95,040 | -29.75% | ||
| 2023-06-22 | Sale | SVP, Chief Commercial Officer | 500 0.0003% | $200.00 | $100,000 | -33.81% | ||
| 2023-05-22 | Sale | SVP, Chief Commercial Officer | 5,000 0.0032% | $208.59 | $1.04M | -34.05% | ||
| 2023-03-01 | Sale | SVP, Chief People Officer | 3,917 0.0025% | $199.06 | $779,737 | -19.52% | ||
| 2023-02-22 | Sale | SVP, Chief Technology Officer | 5,398 0.0034% | $201.74 | $1.09M | -17.67% | ||
| 2023-02-06 | Sale | SVP, Chief Commercial Officer | 500 0.0003% | $211.57 | $105,785 | -12.16% | ||
| 2023-01-09 | Sale | SVP, Chief People Officer | 871 0.0005% | $205.57 | $179,051 | -9.26% | ||
| 2023-01-06 | Sale | SVP, Chief Commercial Officer | 500 0.0003% | $204.58 | $102,290 | -6.35% | ||
| 2022-12-06 | Sale | SVP, Chief Commercial Officer | 500 0.0003% | $212.63 | $106,315 | -5.57% | ||
| 2022-11-08 | Sale | SVP, Chief Technology Officer | 361 0.0002% | $218.00 | $78,698 | -8.48% | ||
| 2022-11-07 | Sale | SVP, Chief Commercial Officer | 500 0.0003% | $223.65 | $111,825 | -8.07% | ||
| 2022-11-07 | Sale | SVP, Chief People Officer | 1,045 0.0007% | $223.65 | $233,714 | -8.07% | ||
| 2022-10-06 | Sale | SVP, Chief Commercial Officer | 500 0.0003% | $216.59 | $108,295 | -4.75% | ||
| 2022-07-05 | Sale | SVP, Chief Technology Officer | 539 0.0004% | $200.00 | $107,800 | +7.40% | ||
| 2022-06-10 | Sale | SVP, Chief Commercial Officer | 250 0.0002% | $214.85 | $53,713 | +1.44% | ||
| 2022-04-28 | Sale | SVP & General Counsel | 368 0.0002% | $300.13 | $110,448 | -30.39% | ||
| 2022-04-12 | Sale | SVP, Chief People Officer | 100 <0.0001% | $355.38 | $35,538 | -38.64% |
Insider Historical Profitability
| Thaysen Jacob | Chief Executive Officer | 14861 0.0094% | $136.02 | 1 | 0 | |
| MOELLER GERALD | director | 17544 0.0111% | $136.02 | 1 | 5 | +43.15% |
| BOWMAN A BLAINE | director | 16868 0.0106% | $136.02 | 11 | 36 | <0.0001% |
Institutional Investor Ownership
| The Vanguard Group | $2.51B | 11.45 | 18.25M | +0.37% | +$9.14M | 0.05 | |
| BlackRock | $1.9B | 8.67 | 13.81M | +3.82% | +$69.77M | 0.04 | |
| State Street | $935.46M | 4.28 | 6.81M | +1.32% | +$12.18M | 0.04 | |
| Edgewood Management | $913.97M | 4.18 | 6.66M | -3.24% | -$30.59M | 2.46 | |
| Baillie Gifford Co | $787.72M | 3.6 | 5.74M | +8.73% | +$63.26M | 0.61 |